Literature detail

Middle East respiratory syndrome coronavirus neutralising serum antibodies in dromedary camels: a comparative serological study.

Chantal B E M Reusken1 Bart L Haagmans Marcel A Müller Carlos Gutierrez Gert-Jan Godeke Benjamin Meyer Doreen Muth V Stalin Raj Laura Smits-De Vries Victor M Corman Jan-Felix Drexler Saskia L Smits Yasmin E El Tahir Rita De Sousa Janko van Beek Norbert Nowotny Kees van Maanen Ezequiel Hidalgo-Hermoso Berend-Jan Bosch Peter Rottier Albert Osterhaus Christian Gortázar-Schmidt Christian Drosten Marion P G Koopmans
Affiliations 1 institutions
  1. Centre for Infectious Disease Research, Diagnostics and Screening, Division Virology, National Institute for Public Health and the Environment, Bilthoven, Netherlands. Electronic address: [email protected].
PMID 23933067 2013 Lancet Infect Dis eng ppublish
PubMed DOI Browse context

Article

Publication summary

A new betacoronavirus-Middle East respiratory syndrome coronavirus (MERS-CoV)-has been identified in patients with severe acute respiratory infection. Although related viruses infect bats, molecular clock analyses have been unable to identify direct ancestors of MERS-CoV. Anecdotal exposure histories suggest that patients had been in contact with dromedary camels or goats. We investigated possible animal reservoirs of MERS-CoV by assessing specific serum antibodies in livestock. We took sera from animals in the Middle East (Oman) and from elsewhere (Spain, Netherlands, Chile). Cattle (n=80), sheep (n=40), goats (n=40), dromedary camels (n=155), and various other camelid species (n=34) were tested for specific serum IgG by protein microarray using the receptor-binding S1 subunits of spike proteins of MERS-CoV, severe acute respiratory syndrome coronavirus, and human coronavirus OC43. Results were confirmed by virus neutralisation tests for MERS-CoV and bovine coronavirus. 50 of 50 (100%) sera from Omani camels and 15 of 105 (14%) from Spanish camels had protein-specific antibodies against MERS-CoV spike. Sera from European sheep, goats, cattle, and other camelids had no such antibodies. MERS-CoV neutralising antibody titres varied between 1/320 and 1/2560 for the Omani camel sera and between 1/20 and 1/320 for the Spanish camel sera. There was no evidence for cross-neutralisation by bovine coronavirus antibodies. MERS-CoV or a related virus has infected camel populations. Both titres and seroprevalences in sera from different locations in Oman suggest widespread infection. European Union, European Centre For Disease Prevention and Control, Deutsche Forschungsgemeinschaft.

Animals Antibodies, Neutralizing Antibodies, Viral Camelids, New World Camelus Cattle Coronavirus Female Goats Humans Immunoglobulin G Male Sheep

Structured evidence records

Evidence records

3 total
2 records
Extraction confidence 0.95
Key finding

Serological surveillance detected high prevalence of MERS-CoV neutralising antibodies in dromedary camels from Oman and Spain, indicating widespread prior infection.

Virus
Location
Supporting text

We took sera from animals in the Middle East (Oman) and from elsewhere (Spain, Netherlands, Chile)... dromedary camels (n=155)... were tested for specific serum IgG by protein microarray using the receptor-binding S1 subunits of spike proteins of MERS-CoV... Results were confirmed by virus neutralisation tests... 50 of 50 (100%) sera from Omani camels and 15 of 105 (14%) from Spanish camels had protein-specific antibodies against MERS-CoV spike.

Method
serology; protein microarray; virus neutralisation test
Sample type
serum
Geographic raw
Oman
Country inferred
Oman
Extraction confidence 0.90
Key finding

Serological evidence of MERS-CoV exposure was detected in Spanish dromedary camels.

Virus
Location
Supporting text

15 of 105 (14%) from Spanish camels had protein-specific antibodies against MERS-CoV spike.

Method
serology; protein microarray; virus neutralisation test
Sample type
serum
Geographic raw
Spain
Country inferred
Spain
1 records
Extraction confidence 1.00
Key finding

Dromedary camels from Oman and Spain had neutralising antibodies to MERS-CoV with seroprevalences of 100% and 14%, respectively, indicating infection of camel populations by MERS-CoV or a related virus.

Virus
Location
Not specified
Supporting text

50 of 50 (100%) sera from Omani camels and 15 of 105 (14%) from Spanish camels had protein-specific antibodies against MERS-CoV spike. MERS-CoV neutralising antibody titres varied between 1/320 and 1/2560 for the Omani camel sera and between 1/20 and 1/320 for the Spanish camel sera.

Method
protein microarray; virus neutralisation test
Sample type
serum